The Diagnostic Value of ACSL1, ACSL4, and ACSL5 and the Clinical Potential of an ACSL Inhibitor in Non-Small-Cell Lung Cancer

Yunxia Ma(Jena University Hospital), Nikolaus Gaßler(Jena University Hospital)

Cancers

March 16, 2024

10.3390/cancers16061170

Cited by 24

Related Papers

Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury

|Gut|2011|608

TAK1 Suppresses a NEMO-Dependent but NF-κB-Independent Pathway to Liver Cancer

|Cancer Cell|2010|220

Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer

|Gut|2012|179

RIP3 Inhibits Inflammatory Hepatocarcinogenesis but Promotes Cholestasis by Controlling Caspase-8- and JNK-Dependent Compensatory Cell Proliferation

|Cell Reports|2013|132

Fluorescein-Guided Panendoscopy for Head and Neck Cancer Using Handheld Probe-Based Confocal Laser Endomicroscopy: A Pilot Study

|Frontiers in Oncology|2021|22